Other drugs had no effect, and one, furosemide, raised kidney risk.
其他药物并没有影响，一，速尿，提出了肾的风险。
One out of every six people hospitalized with heart failure were given Natrecor until it came under a cloud in 2005 when studies suggested it raised the risk of death and kidney problems.
当时，每六个因心衰住院的患者中有一个会被要求服用奈西立肽。直到2005年，多项研究证实，奈西立肽会增加死亡和肾脏问题的风险。到这时，它才失去了市场。
应用推荐